Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

708 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Imaging of Neuroendocrine Neoplasms; Principles of Treatment Strategies. What Referring Clinicians Want to Know.
Asmundo L, Ambrosini V, Mojtahed A, Fanti S, Ferrone C, Hesami M, Sertic M, Najmi Z, Furtado FS, Dhami RS, Anderson MA, Samir A, Sharma A, Campana D, Ursprung S, Nikolau K, Domachevsky L, Blake MA, Norris EC, Clark JW, Catalano OA. Asmundo L, et al. Among authors: fanti s. J Comput Assist Tomogr. 2024 Apr 12. doi: 10.1097/RCT.0000000000001619. Online ahead of print. J Comput Assist Tomogr. 2024. PMID: 38626751
Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update.
Di Franco M, Zanoni L, Fortunati E, Fanti S, Ambrosini V. Di Franco M, et al. Among authors: fanti s. Curr Oncol Rep. 2024 May;26(5):538-550. doi: 10.1007/s11912-024-01526-5. Epub 2024 Apr 6. Curr Oncol Rep. 2024. PMID: 38581469 Free PMC article. Review.
Clinical Intricacies and Advances in Neuroendocrine Tumors: An Organ-Based Multidisciplinary Approach.
Asmundo L, Ambrosini V, Anderson MA, Fanti S, Bradley WR, Campana D, Mojtahed A, Chung R, Mcdermott S, Digumarthy S, Ursprung S, Nikolau K, Fintelmann FJ, Blake M, Fernandez-Del Castillo C, Qadan M, Pandey A, Clark JW, Catalano OA. Asmundo L, et al. Among authors: fanti s. J Comput Assist Tomogr. 2024 Apr 15. doi: 10.1097/RCT.0000000000001596. Online ahead of print. J Comput Assist Tomogr. 2024. PMID: 38626756
Case of the month from the Radiotherapy Unit, Department of Medical and Surgical Sciences, University of Bologna, Italy: breaking boundaries beyond five lesions with multifocal stereotactic radiotherapy in prostate cancer.
Galietta E, Strolin S, Lodi-Rizzini E, Castellucci P, Cilla S, Buwenge M, Vadala' M, Fanti S, Ntreta M, Strigari L, Morganti AG. Galietta E, et al. Among authors: fanti s. BJU Int. 2024 May 22. doi: 10.1111/bju.16399. Online ahead of print. BJU Int. 2024. PMID: 38775027 No abstract available.
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report.
Tassinari E, Conci N, Battisti G, Porta F, Di Scioscio V, Pirini MG, de Biase D, Nigro MC, Iezza M, Castagnetti F, Lovato L, Fanti S, Pantaleo MA, Nannini M. Tassinari E, et al. Among authors: fanti s. Front Oncol. 2023 Dec 20;13:1310452. doi: 10.3389/fonc.2023.1310452. eCollection 2023. Front Oncol. 2023. PMID: 38188286 Free PMC article.
Radioiodine whole body scan pitfalls in differentiated thyroid cancer.
Basso C, Colapinto A, Vicennati V, Gambineri A, Pelusi C, Di Dalmazi G, Rizzini EL, Tabacchi E, Golemi A, Calderoni L, Fanti S, Pagotto U, Repaci A. Basso C, et al. Among authors: fanti s. Endocrine. 2024 Mar 18. doi: 10.1007/s12020-024-03754-y. Online ahead of print. Endocrine. 2024. PMID: 38498129 Review.
NTRK rearranged sarcoma of the bone. Role for larotrectinib in the neoadjuvant setting of an ultra-rare tumor: a case report.
Palmerini E, Frega G, Gambarotti M, Frisoni T, Cesari M, Bazzocchi A, Miceli M, Donati DM, Fanti S, Nanni C, Benini S, Longhi A, Paioli A, Marrari A, Hakim R, Righi A, Ibrahim T. Palmerini E, et al. Among authors: fanti s. Front Oncol. 2023 Oct 9;13:1252359. doi: 10.3389/fonc.2023.1252359. eCollection 2023. Front Oncol. 2023. PMID: 37876963 Free PMC article.
Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection.
Droghetti M, Bianchi L, Presutti M, Vetrone L, Farolfi A, Mei R, Giunchi F, Degiovanni A, Mottaran A, Piazza P, Cangemi D, Castellucci P, D'Errico A, Schiavina R, Brunocilla E, Fanti S. Droghetti M, et al. Among authors: fanti s. Front Oncol. 2024 May 14;14:1324631. doi: 10.3389/fonc.2024.1324631. eCollection 2024. Front Oncol. 2024. PMID: 38807770 Free PMC article.
A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA, and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experience.
Mollica V, Marchetti A, Fraccascia N, Nanni C, Tabacchi E, Malizia C, Argalia G, Rosellini M, Tassinari E, Paccapelo A, Fanti S, Massari F. Mollica V, et al. Among authors: fanti s. ESMO Open. 2024 May;9(5):103448. doi: 10.1016/j.esmoop.2024.103448. Epub 2024 May 7. ESMO Open. 2024. PMID: 38718704 Free PMC article. Clinical Trial.
708 results